New Zealand - engelsk - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - gemcitabine hydrochloride 228mg equivalent to 200 mg gemcitabine free base - powder for infusion - 200 mg - active: gemcitabine hydrochloride 228mg equivalent to 200 mg gemcitabine free base excipient: hydrochloric acid mannitol nitrogen sodium acetate sodium hydroxide

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - pegaptanib sodium 3.47 mg/ml - solution for injection - 300 mcg/dose - active: pegaptanib sodium 3.47 mg/ml excipient: dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate sodium chloride water for injection

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 8 g/l;  ;  ;  ; arginine 8.4 g/l;  ;  ;  ; aspartic acid 6 g/l;  ;  ; cysteine 1.89 g/l;  ; glutamic acid 10 g/l;  ; glycine 4 g/l;  ;  ; histidine 3.8 g/l;  ;  ; isoleucine 6.7 g/l;  ;  ;  ;  ;  ; leucine 10 g/l;  ;  ;  ;  ; lysine 11 g/l; methionine 2.4 g/l;  ;  ; ornithine hydrochloride 3.18 g/l;  ; phenylalanine 4.2 g/l;  ;  ;  ;  ; proline 3 g/l;  ;  ; serine 4 g/l;  ;  ; taurine 0.6 g/l;  ; threonine 3.7 g/l;  ;  ;  ; tryptophan 2 g/l;  ;  ;  ; tyrosine 0.45 g/l;  ;  ; valine 7.6 g/l;  ;   - solution for infusion - 10 % - active: alanine 8 g/l       arginine 8.4 g/l       aspartic acid 6 g/l     cysteine 1.89 g/l   glutamic acid 10 g/l   glycine 4 g/l     histidine 3.8 g/l     isoleucine 6.7 g/l           leucine 10 g/l         lysine 11 g/l methionine 2.4 g/l     ornithine hydrochloride 3.18 g/l   phenylalanine 4.2 g/l         proline 3 g/l     serine 4 g/l     taurine 0.6 g/l   threonine 3.7 g/l       tryptophan 2 g/l       tyrosine 0.45 g/l     valine 7.6 g/l     excipient: malic acid water for injection - primene 10% amino acids iv infusion solution is indicated in infants and neonates at term or premature for short-term use, of normal or low birth-weight when oral or enteral nutrition is impossible, insufficient or contraindicated. it is used as an amino acid component in a composite admixture of total parenteral solution.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 12 g/l;  ;  ;  ; arginine 8.4 g/l (l-arginine);  ;  ; aspartic acid 2.5 g/l (l-aspartic acid);  ;  ; calcium gluconate monohydrate 2.24 g/l;  ; cysteine 0.42 g/l (as l-cysteine hydrochloride); glutamic acid 4.2 g/l (l-glutamic acid);  ;  ; glycine 5.9 g/l (as aminoacetic acid);  ;  ; histidine 5.1 g/l (l-histidine);  ;  ; isoleucine 4.2 g/l (l-isoleucine);  ;  ;  ; leucine 5.9 g/l (l-leucine);  ;  ;  ; lysine hydrochloride 6.8 g/l;  ;  ;  ; magnesium sulfate heptahydrate 1.97 g/l; methionine 4.2 g/l (l-methionine);  ;  ; phenylalanine 5.9 g/l (l-phenylalanine);  ;  ;  ; potassium chloride 3.73 g/l; proline 5.1 g/l (l-proline);  ; serine 3.4 g/l (l-serine);  ;  ;  ;  ; sodium acetate trihydrate 13.6 g/l;  ;  ; threonine 4.2 g/l (l-threonine);  ;  ;  ; tryptophan 1.4 g/l (l-tryptophan);  ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine);  ;   - solution for infusion - active: alanine 12 g/l       arginine 8.4 g/l (l-arginine)     aspartic acid 2.5 g/l (l-aspartic acid)     calcium gluconate monohydrate 2.24 g/l   cysteine 0.42 g/l (as l-cysteine hydrochloride) glutamic acid 4.2 g/l (l-glutamic acid)     glycine 5.9 g/l (as aminoacetic acid)     histidine 5.1 g/l (l-histidine)     isoleucine 4.2 g/l (l-isoleucine)       leucine 5.9 g/l (l-leucine)       lysine hydrochloride 6.8 g/l       magnesium sulfate heptahydrate 1.97 g/l methionine 4.2 g/l (l-methionine)     phenylalanine 5.9 g/l (l-phenylalanine)       potassium chloride 3.73 g/l proline 5.1 g/l (l-proline)   serine 3.4 g/l (l-serine)         sodium acetate trihydrate 13.6 g/l     threonine 4.2 g/l (l-threonine)       tryptophan 1.4 g/l (l-tryptophan)   tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine)     excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - verteporfin 15mg - powder for infusion - 15 mg - active: verteporfin 15mg excipient: ascorbyl palmitate butylated hydroxytoluene dimyristoylphosphatidylcholine lactose monohydrate phosphatidylglycerols - visudyne is indicated for the treatment of patients with predominately classic or occult subfoveal choroidal neovascularisation due to age-related macular degeneration (amd), or with subfoveal choroidal neovascularisation caused by other macular diseases.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

viatris limited - azelastine hydrochloride 1.5 mg/ml - nasal spray solution - 0.15% w/v - active: azelastine hydrochloride 1.5 mg/ml excipient: benzalkonium chloride disodium edetate hypromellose purified water sodium citrate sorbitol sucralose - for the treatment of hay-fever symptoms caused by seasonal and non-seasonal allergies including pollen, house mites and pet hair

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

viatris limited - azelastine hydrochloride 1 mg/g ((137 micrograms/spray)); fluticasone propionate 0.365 mg/g ((50 micrograms/spray)) - nasal spray suspension - active: azelastine hydrochloride 1 mg/g ((137 micrograms/spray)) fluticasone propionate 0.365 mg/g ((50 micrograms/spray)) excipient: benzalkonium chloride disodium edetate glycerol microcrystalline cellulose and carmellose sodium nitrogen phenethyl alcohol polysorbate 80 purified water - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

reckitt benckiser (new zealand) limited - potassium bicarbonate 20 mg/ml; sodium alginate 100 mg/ml - oral solution - active: potassium bicarbonate 20 mg/ml sodium alginate 100 mg/ml excipient: calcium carbonate carbomer 974 methyl hydroxybenzoate peppermint flavour phl-003452 propyl hydroxybenzoate purified water saccharin sodium sodium hydroxide - gaviscon pregnancy brings fast, soothing and long lasting relief from the pain and discomfort of heartburn (gastric reflux) and indigestion. (label claim).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - alectinib hydrochloride 161.33mg equivalent to alectinib 150mg - capsule - 150 mg - active: alectinib hydrochloride 161.33mg equivalent to alectinib 150mg excipient: black ink (alecensa) carmellose calcium carnauba wax carrageenan hyprolose hypromellose lactose monohydrate magnesium stearate maize starch potassium chloride sodium laurilsulfate titanium dioxide - alecensa is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive, locally advanced or metastatic non-small cell lung cancer (nsclc).

Israel - engelsk - Ministry of Health

dor pharmaceutical services ltd., israel - afamelanotide as acetate - implant - afamelanotide as acetate 16 mg - afamelanotide - scenesse is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp).